Adalimumab for the treatment of pediatric psoriasis: a single center experience of 4 cases

G Ital Dermatol Venereol. 2020 Oct;155(5):693-695. doi: 10.23736/S0392-0488.19.06096-6. Epub 2019 Feb 14.

Authors

Matteo Licciardello¹, Veronica Arese¹, Michele Panzone¹, Paolo Dapavo¹, Simone Ribero¹, Maria T Fierro¹, Pietro Quaglino²

Affiliations

¹ Unit of Dermatology, Department of Medical Sciences, Molinette Hospital, Città della Salute e della Scienza, Turin, Italy.
² Unit of Dermatology, Department of Medical Sciences, Molinette Hospital, Città della Salute e della Scienza, Turin, Italy - pietro.quaglino@unito.it.

PMID: 30762029
DOI: 10.23736/S0392-0488.19.06096-6

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adalimumab / therapeutic use*
Adolescent
Anti-Inflammatory Agents / therapeutic use*
Humans
Male
Psoriasis / drug therapy*

Substances

Anti-Inflammatory Agents
Adalimumab